{"cohort":"NCI-60","url":"https://discover.nci.nih.gov/cellminer/, https://www.ncbi.nlm.nih.gov/pubmed/?term=20215517","probeMap":"probeMap/affyU133_hg19","dataSubType":"gene expression","citation":"Cancer Res. 2010 Mar 15;70(6):2191-203.","label":"RNA: Affy HG-U133 Plus 2.0 RMA value","articletitle":"Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron.","name":"NCI60/RNA_Affy_HG_U133_Plus_2.0_RMA.txt","dataproducer":"Reinhold WC, Mergny JL, Liu H, Ryan M, Pfister TD, Kinders R, Parchment R, Doroshow J, Weinstein JN, Pommier Y.","type":"genomicMatrix","version":"2018-09-06","unit":"RMA","pmid":20215517}

{"longTitle":"Neuroblastoma Affymetrix Gene Expression","cohort":"Neuroblastoma (Khan)","url":"http://pob.abcc.ncifcrf.gov/cgi-bin/JK","probeMap":"probeMap/affyU133_ucscGenomeBrowser_hg18.probeMap","dataSubType":"gene expression","label":"gene expression","tags":["cancer","neural","pediatric"],"path":"data_flatten/public/other/neuroblastoma_affy/expression","anatomical_origin":["Adrenal gland"],"name":"Khan_neuroblastoma/expression","dataproducer":"Javed Khan group","wrangling_procedure":"Download log2 ratios from dataset called Neuroblastoma Affymetrix Database","sample_type":["tumor"],"type":"genomicMatrix","version":"2013-09-26","gdata_tags":["transcription","mRNA"],"primary_disease":"neuroblastoma","colnormalization":true,"description":"Neuroblastoma Affymetrix Database data from Oncogenomics database developed by Javed Khan group.<br><br>"}

{"longTitle":"76-gene Prognostic Signature Lymph-Node-Negative Gene Expression (Desmedt et al. CCR 2007)","cohort":"Node-negative breast cancer (Desmedt 2007)","url":"http://www.ncbi.nlm.nih.gov/pubmed/17545524","probeMap":"probeMap/affyU133_ucscGenomeBrowser_hg18.probeMap","dataSubType":"gene expression","citation":"Clin Cancer Res. 2007 Jun 1;13(11):3207-14.","label":"Desmedt 76 Gene Node-Neg Gene Exp","articletitle":"Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.","tags":["cancer"],"anatomical_origin":["Breast"],"name":"desmedt2007_public/desmedt2007_genomicMatrix","dataproducer":"Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y, d'Assignies MS, Bergh J, Lidereau R, Ellis P, Harris AL, Klijn JG, Foekens JA, Cardoso F, Piccart MJ, Buyse M, Sotiriou C; TRANSBIG Consortium.","sample_type":["tumor"],"type":"genomicMatrix","version":"2011-11-01","gdata_tags":["transcription","mRNA"],"primary_disease":"breast cancer"}